ReviewClinical, cosmetic and investigational dermatology2026
Current Perspectives on Photodynamic Therapy for Skin Diseases: A Narrative Review.
Review in Clinical, cosmetic and investigational dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photodynamic therapy (PDT) is a minimally invasive treatment widely used in dermatology for various skin diseases. It works through the interaction of a photosensitizer, light, and oxygen, producing reactive oxygen species that selectively destroy abnormal cells. PDT is well established in treating conditions such as actinic keratosis, Bowen's disease, and superficial basal cell carcinoma, with good cosmetic outcomes. Increasing evidence also supports its use in non-cancerous conditions, including acne, photoaging, and certain infections. Despite its advantages, limitations such as treatment-related pain and reduced effectiveness in thicker lesions remain challenges. Ongoing research aims to improve photosensitizers, delivery methods, and light technologies to enhance its clinical effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.